Robins Harlan S's Form 4 filing
Adaptive Biotechnologies Corp (ADPT) · filed Mar 13, 2026
- Accession no.
- 0001780851-26-000007
- Filed
- Mar 13, 2026
- Trade date
- Mar 11, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $6.19M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robins Harlan SCIK 0001780851 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Common Stock | SSaleDisposed | −140,666 | $13.17 | −$1,852,571.22 | 1,851,658 | Direct | |
| Mar 11, 2026 | Common Stock | SSaleDisposed | −329,600 | $13.17 | −$4,340,832 | 1,522,058 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.